| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |